ACUTE MYELOID LEUKAEMIA (AML)
Clinical trials for ACUTE MYELOID LEUKAEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug RVU120 gets extended trial for ongoing patients
Disease control ENROLLING_BY_INVITATIONThis study offers continued RVU120 treatment to up to 10 patients with advanced solid tumors, acute myeloid leukemia, or high-risk myelodysplastic syndrome who are already benefiting from the drug in an earlier trial. The main goal is to monitor safety and see how long patients c…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New chemo combo aims to boost leukemia survival after transplant
Disease control OngoingThis phase 2 trial tests a combination of two chemotherapy drugs, fludarabine and treosulfan, given before a stem cell transplant in adults aged 40-65 with acute myeloid leukemia (AML) in remission. The goal is to see if this conditioning regimen improves the chance of being aliv…
Matched conditions: ACUTE MYELOID LEUKAEMIA (AML)
Phase: PHASE2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC